Skip to content
value.today

Sunshine Heart, Inc.

Total raised
$12 M
4 rounds on record
Latest round
$2 M
Jan 2013
First round on record
Nov 2010
Today
Went public
See the company page

Sunshine Heart, Inc. is listed today as Nuwellis, Inc.: market value, financials and filings are on its company page.

Funding rounds

4 counted as startup funding, 7 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Sunshine Heart, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2024$4 MPrivate placement after listing$2 to $10 million

Sunshine Heart, Inc.: Private sale, Nov 2024

Investors in this round

9 investors had bought by the notice of Nov 20, 2024: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
$382,863
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Neil P. Ayotte · Executive Officer
  • Nestor L. Jaramillo, Jr. · Executive Officer, Director
  • Rob Kendrick Scott · Executive Officer
  • Archelle L. Georgiou, M.D. · Director
  • Dave Kendrick McDonald · Director
  • Gregory L. Waller · Director
  • John L. Erb · Director
  • Maria Rosa L. Costanzo, M.D. · Director
  • Mike L. McCormick · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in CA, CT, DE, FL, IL, NV, NY

Remarks in the notice

  • On fees: “A fee equal to 8% of the gross proceeds received from the Inducement Offer will be paid to the placement agent, along with legal fees and expenses, and warrants to purchase up to 54,976 shares of common stock at an exercise price of $3.465.”
  • On the amounts: “In connection with a warrant inducement offering, warrants to purchase up to 3,720,010 shares of common stock were issued in a private placement. The offering amount excludes proceeds of up to $7,300,658 from the exercise of the warrants.”

Signed by Rob Scott, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 20, 2024. Read the notice at the SEC.

optionsSEC
May 2020$2 MPrivate placement after listingUnder $2 million

Sunshine Heart, Inc.: Private sale, May 2020

Investors in this round

4 investors had bought by the notice of May 7, 2020: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$136,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Claudia L. Drayton · Executive Officer
  • John L. Erb · Executive Officer, Director
  • Gregory Rosa Waller · Director
  • Jon Rosa Salveson · Director
  • Maria Rosa Costanzo · Director
  • Steve L. Brandt · Director
  • Warren S. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “Total offering amount includes the concurrent registered offering of common stock and excludes proceeds totaling up to $737,565 from the exercise of the warrants.”
  • On the use of proceeds: “The Company intends to use the net proceeds for general corporate purposes, including the continued investment in commercialization efforts and increasing production of the Aquadex SmartFlow system to address the COVID-19 pandemic.”

Signed by Claudia Drayton, Chief Financial Officer. Source: SEC Form D, newest notice filed May 7, 2020. Read the notice at the SEC.

equity, optionsSEC
Apr 2020$2 MPrivate placement after listing$2 to $10 million

Sunshine Heart, Inc.: Private sale, Apr 2020

Investors in this round

4 investors had bought by the notice of Apr 8, 2020: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$178,121
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Claudia L. Drayton · Executive Officer
  • John L. Erb · Executive Officer, Director
  • Gregory Rosa Waller · Director
  • Jon Rosa Salveson · Director
  • Maria Rosa Costanzo · Director
  • Steve L. Brandt · Director
  • Warren S. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “Total offering amount includes the concurrent registered offering of common stock and excludes proceeds totaling up to $1,113,259 from the exercise of the warrants.”
  • On the use of proceeds: “Proceeds to be used for working capital and general corporate purposes.”

Signed by Claudia Drayton, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 8, 2020. Read the notice at the SEC.

equity, optionsSEC
Mar 2020$1 MPrivate placement after listingUnder $2 million

Sunshine Heart, Inc.: Private sale, Mar 2020

Investors in this round

4 investors had bought by the notice of Mar 30, 2020: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$99,873
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Claudia L. Drayton · Executive Officer
  • John L. Erb · Executive Officer, Director
  • Gregory Rosa Waller · Director
  • Jon Rosa Salveson · Director
  • Maria Rosa Costanzo · Director
  • Steve L. Brandt · Director
  • Warren S. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “Total offering amount includes the concurrent registered offering of common stock and excludes proceeds totaling up to $1,248,418 from the exercise of the warrants.”
  • On the use of proceeds: “Proceeds to be used for working capital and general corporate purposes.”

Signed by Claudia Drayton, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 30, 2020. Read the notice at the SEC.

equity, optionsSEC
Nov 2019$1 MPrivate placement after listingUnder $2 million

Sunshine Heart, Inc.: Private sale, Nov 2019

Investors in this round

3 investors had bought by the notice of Nov 21, 2019: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$109,229
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Claudia L. Drayton · Executive Officer
  • John L. Erb · Executive Officer, Director
  • Gregory Rosa Waller · Director
  • Jon Rosa Salveson · Director
  • Maria Rosa Costanzo · Director
  • Steve L. Brandt · Director
  • Warren S. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “Total offering amount includes the concurrent registered offering of common stock and excludes proceeds totaling up to $1,212,005 from the exercise of the warrants.”
  • On the use of proceeds: “Proceeds to be used for working capital and general corporate purposes.”

Signed by Claudia Drayton, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 21, 2019. Read the notice at the SEC.

equity, optionsSEC
Oct 2016$4 MPrivate placement after listing$2 to $10 million

Sunshine Heart, Inc.: Private sale, Oct 2016

Investors in this round

2 investors had bought by the notice of Nov 9, 2016: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$216,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Claudia L. Drayton · Executive Officer
  • Eric L. Lovett · Executive Officer
  • John L. Erb · Executive Officer, Director
  • Molly L. Wade · Executive Officer
  • Gregory L. Waller · Director
  • Jon L. Salveson · Director
  • Warren S. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Northland Securities, Inc. (CRD 40258) · Minneapolis, MinnesotaSold in NJ, NY

Remarks in the notice

  • On fees: “Excludes 1,270,588 warrants to purchase common stock received by placement agent as part of its compensation.”
  • On the amounts: “Total offering amount includes the concurrent registered offering of preferred stock and excludes proceeds totaling up to $3,811,765 from the exercise of the warrants.”
  • On the use of proceeds: “Proceeds to be used for working capital and general corporate purposes.”

Signed by Claudia Drayton, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 9, 2016. Read the notice at the SEC.

equity, optionsSEC
Jul 2016$3 MPrivate placement after listing$2 to $10 million

Sunshine Heart, Inc.: Private sale, Jul 2016

Investors in this round

2 investors had bought by the notice of Aug 2, 2016: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$208,080
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Claudia L. Drayton · Executive Officer
  • Eric L. Lovett · Executive Officer
  • John L. Erb · Executive Officer, Director
  • Molly L. Wade · Executive Officer
  • Gregory L. Waller · Director
  • Jon L. Salveson · Director
  • Paul L. Buckman · Director
  • Warren S. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Northland Securities, Inc. (CRD 40258) · Minneapolis, MinnesotaSold in NJ, NY

Remarks in the notice

  • On fees: “Excludes 221,362 warrants to purchase common stock received by placement agent as part of its compensation.”
  • On the amounts: “Total offering amount includes the concurrent registered offering of preferred stock and excludes proceeds totaling up to $3,468,000 from the exercise of the warrants.”
  • On the use of proceeds: “Proceeds to be used for working capital and general corporate purposes.”

Signed by Claudia Drayton, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 2, 2016. Read the notice at the SEC.

optionsSEC
Jan 2013$2 MNo. 4Under $2 million

Sunshine Heart, Inc.: Raise no. 4, Jan 2013

Investors in this round

1 investor had bought by the notice of May 20, 2013: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $26 M offered; $24 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David A. Rosa · Executive Officer, Director
  • Debra J. Kridner · Executive Officer
  • Jeffrey S. Mathiesen · Executive Officer
  • Kevin P. Bassett · Executive Officer
  • William S. Peters · Executive Officer
  • Geoffrey E. Brooke · Director
  • Gregory D. Waller · Director
  • John L. Erb · Director
  • John W. Salveson · Director
  • Paul R. Buckman · Director
  • Warren S. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total amount sold represents value of amount of common stock (i) issued to the investor for payment of the commitment fee payable by the Issuer pursuant to the terms of the subject financing and (ii) sold to the investor as of the date hereof.”

Signed by Jeffrey S. Mathiesen, Chief Financial Officer. Source: SEC Form D, newest notice filed May 20, 2013. Read the notice at the SEC.

equitySEC
Feb 2012$2 MNo. 3$2 to $10 million

Sunshine Heart, Inc.: Raise no. 3, Feb 2012

Investors in this round

4 investors had bought by the notice of Feb 22, 2012: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$158,458
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David A Rosa · Executive Officer, Director
  • Debra A Kridner · Executive Officer
  • Jeffrey A Mathiesen · Executive Officer
  • Jim A Yearick · Executive Officer
  • Kevin A Bassett · Executive Officer
  • William A Peters · Executive Officer, Director
  • Donal A O'Dwyer · Director
  • Geoffrey A Brooke · Director
  • Gregory A Waller · Director
  • Mark A Harvey · Director
  • Nicholas A Callinan · Director
  • Paul A Buckman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Summer Street Research Partners (CRD 127142) · broker-dealer Nickolay Kukekov (CRD 4981423) · Boston, MassachusettsSold in CT, NY

Signed by Jeffrey Mathiesen, Secretary. Source: SEC Form D, newest notice filed Feb 22, 2012. Read the notice at the SEC.

equity, optionsSEC
Jul 2011$5 MNo. 2$2 to $10 million

Sunshine Heart, Inc.: Raise no. 2, Jul 2011

Investors in this round

9 investors had bought by the notice of Aug 10, 2011: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $15 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$372,722
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David A Rosa · Executive Officer, Director
  • Jeffrey A Mathiesen · Executive Officer
  • William A Peters · Executive Officer, Director
  • Crispin A Marsh · Director
  • Donal A O'Dwyer · Director
  • Geoffrey A Brooke · Director
  • Gregory A Waller · Director
  • Nicholas A Callinan · Director
  • Paul A Buckman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Summer Street Research Partners (CRD 127142) · broker-dealer Matthew Dormer (CRD 4338996) · Boston, MassachusettsSold in AZ, CA, CO, NY, and outside the US

Signed by Jeffrey Mathiesen, Secretary. Source: SEC Form D, newest notice filed Aug 10, 2011. Read the notice at the SEC.

equity, optionsSEC
Nov 2010$4 MNo. 1$2 to $10 million

Sunshine Heart, Inc.: Raise no. 1, Nov 2010

Investors in this round

7 investors had bought by the notice of Nov 24, 2010: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$262,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David A. Rosa · Executive Officer, Director
  • Rowena A. Hubble · Executive Officer
  • William A. Peters · Executive Officer, Director
  • Crispin A. Marsh · Director
  • Donal A. O'Dwyer · Director
  • Geoffrey A. Brooke · Director
  • John A. Brennan · Director
  • Nicholas A. Callinan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Summer Street Research Partners (CRD 127142) · broker-dealer Matthew Dormer (CRD 4338996) · Boston, MassachusettsSold in CA, MA, NY

Remarks in the notice

  • On the amounts: “Original Offering was up to $11,000,000. $3,500,000 was sold, and offering has now closed.”

Signed by David A. Rosa, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 24, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Nuwellis, Inc., its revenue in fiscal 2025 came from these business segments: Fluid Overload $8.27 million (100%).

    Annual report (SEC XBRL) · Dec 2025

  • Sunshine Heart, Inc. had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Nov 2024).

    SEC Form D (revenue range) · Nov 2024

  • Revenue range over time, as stated in its notices: revenue of up to $1 million in 2010; revenue of up to $1 million in 2011; revenue of up to $1 million in 2012; revenue between $5 million and $25 million in 2024.

    SEC Form D (revenue range) · Nov 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Nov 2024

Products and services#

No products or services of Sunshine Heart, Inc. are on record.

Investors#

No investor of Sunshine Heart, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 9 investors.

Largest shareholders today

Institutions holding Nuwellis, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sunshine Heart, Inc.
NameRoleNamed in
Neil P. AyotteExecutive officerNov 2024
Nestor L. Jaramillo, Jr.Executive officerNov 2024
Rob Kendrick ScottExecutive officerNov 2024
Claudia L. DraytonExecutive officerMay 2020
John L. ErbExecutive officerMay 2020
Eric L. LovettExecutive officerNov 2016
Molly L. WadeExecutive officerNov 2016
David A. RosaExecutive officerMay 2013
Debra J. KridnerExecutive officerMay 2013
Jeffrey S. MathiesenExecutive officerMay 2013
Kevin P. BassettExecutive officerMay 2013
William S. PetersExecutive officerMay 2013
David A RosaExecutive officerFeb 2012
Debra A KridnerExecutive officerFeb 2012
Jeffrey A MathiesenExecutive officerFeb 2012
Jim A YearickExecutive officerFeb 2012
Kevin A BassettExecutive officerFeb 2012
William A PetersExecutive officerFeb 2012
Rowena A. HubbleExecutive officerNov 2010
William A. PetersExecutive officerNov 2010
Archelle L. Georgiou, M.D.DirectorNov 2024
Dave Kendrick McDonaldDirectorNov 2024
Gregory L. WallerDirectorNov 2024
John L. ErbDirectorNov 2024
Maria Rosa L. Costanzo, M.D.DirectorNov 2024
Mike L. McCormickDirectorNov 2024
Nestor L. Jaramillo, Jr.DirectorNov 2024
Gregory Rosa WallerDirectorMay 2020
Jon Rosa SalvesonDirectorMay 2020
Maria Rosa CostanzoDirectorMay 2020
Steve L. BrandtDirectorMay 2020
Warren S. WatsonDirectorMay 2020
Jon L. SalvesonDirectorNov 2016
Paul L. BuckmanDirectorAug 2016
David A. RosaDirectorMay 2013
Geoffrey E. BrookeDirectorMay 2013
Gregory D. WallerDirectorMay 2013
John W. SalvesonDirectorMay 2013
Paul R. BuckmanDirectorMay 2013
David A RosaDirectorFeb 2012

Went public since 2013. Its SEC number is that of a company listed on a stock exchange.